Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Extraordinary claims require extraordinary evidence.

Literature DB >> 16087260

Extraordinary claims require extraordinary evidence.

Donald W Light¹, Rebecca N Warburton.

Abstract

Mesh：

Substances：
Drugs, Investigational

Year: 2005 PMID： 16087260 DOI： 10.1016/j.jhealeco.2005.07.001

Source DB: PubMed Journal: J Health Econ ISSN： 0167-6296 Impact factor: 3.883

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Are drugs too expensive in Canada? Yes.

Authors: Joel Lexchin
Journal: Can Fam Physician Date: 2006-05 Impact factor: 3.275

2. Measuring US pharmaceutical industry R&D spending.

Authors: Joseph Golec; John Vernon
Journal: Pharmacoeconomics Date: 2008 Impact factor: 4.981

3. Drug design and discovery: translational biomedical science varies among countries.

Authors: Ian N Weaver; Donald F Weaver
Journal: Clin Transl Sci Date: 2013-04-19 Impact factor: 4.689

4. Cancer care burden: aiming at the Achilles heel.

Authors: S Ahmed; R K Shahid; K Gesy
Journal: Curr Oncol Date: 2015-06 Impact factor: 3.677

5. The Expected Net Present Value of Developing Weight Management Drugs in the Context of Drug Safety Litigation.

Authors: Anita Chawla; Ginger Carls; Edmund Deng; Edward Tuttle
Journal: Pharmacoeconomics Date: 2015-07 Impact factor: 4.981

6. An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) project.

Authors: William J Meurer; Roger J Lewis; Danilo Tagle; Michael D Fetters; Laurie Legocki; Scott Berry; Jason Connor; Valerie Durkalski; Jordan Elm; Wenle Zhao; Shirley Frederiksen; Robert Silbergleit; Yuko Palesch; Donald A Berry; William G Barsan
Journal: Ann Emerg Med Date: 2012-03-15 Impact factor: 5.721

7. Cost effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancer.

Authors: Heather Taffet Gold; Michael J Hall; Victoria Blinder; Bruce R Schackman
Journal: Cancer Date: 2009-09-01 Impact factor: 6.860